# HealthBiome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/healthbiome

- Industry: Biotechnology
- Headquarters: Daejeon-City, South Korea
- Website: www.healthbiome.co.kr
- Total disclosed funding: $7.1M
- Latest round: Series B (Nov 3, 2022)
- Investors on record: 4

## About

Founded in 2017 and based in Daejeon-City, South Korea,  HealthBiome Inc. operates as a bio-venture company with its own effective strains for treating diseases. The company has carried out R&D in microbiome-based drug discovery using strict anaerobic gut microbiota identification and production technology. In December 2020, the company raised an undisclosed amount in series A funding. The company has obtained 3 patents registration of the microbiome-based treatment for Alzheimer’s disease and 2 PCT applications. In September 2019, the company obtained a patent application for the microbiome-based treatment for cancer.

HealthBiome’s research lab is studying the separation of human gut strict anaerobic microbial strains with excellent efficacy in treating cancer, brain nervous, aging diseases, and is also developing microbiome-based disease treatment substances. The company based on the separation technology of unculturable strict anaerobic gut microbiota has identified candidate strains with great efficacy of treating incurable diseases, and has secured its own microbes effective in improving immuno-oncology therapies, CNS disorders as well as metabolic syndromes. The products of the company can be used in disease treatment, preventive functional foods, medical foods, cosmetics, animal medicines and health functional feed.

## Funding rounds

- Series B, Nov 3, 2022, $7.1M — KDB Capital, Solidus Investment, L&S Venture Capital, K-Run Ventures

## Investors

- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series B
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series B
- L&S Venture Capital (https://capitalatlas.ai/funds/l-s-venture-capital) — Series B
- K-Run Ventures (https://capitalatlas.ai/funds/k-run-ventures) — Series B